Tauropace reduces infections in patients with heart failure and reduced ejection fraction after cardiac electronic implantable device implantation.
1 April 2025 (10:30 - 11:15)
Organised by: 

About the speaker

Cardiocentro Ticino Institute, Lugano (Switzerland)
6 More presentations in this session

Mrs M. Upchurch (Minneapolis, US)

Assistant Professor G. Leventopoulos (Patras, GR)
Access the full session
The Event
EHRA 2025
1 April 2025
10:30 CET
You may be interested in
Congress Presentation
Congress Session
8 April 2024

Congress Presentation
Congress Presentation




